Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2013 | 03-2012 | 03-2011 | 03-2010 | 03-2009 | |
| Sales | 3,404 | 2,424 | 4,266 | 3,344 | 2,275 |
| Cost of Goods | 2,315 | 1,014 | 2,675 | 2,306 | 1,465 |
| Gross Profit | 1,088 | 1,410 | 1,591 | 1,039 | 810 |
| Operating Expenses | 2,967 | 3,390 | 3,152 | 3,281 | 7,665 |
| Operating Income | -1,563 | -1,966 | -886 | -1,936 | -6,390 |
| Interest Expense | 393 | 654 | 1,491 | 1,532 | 252 |
| Other Income | 3,090 | -12,922 | -11,507 | -4,589 | 41 |
| Pre-tax Income | 1,134 | -15,542 | -13,884 | -8,057 | -6,602 |
| Income Tax | -354 | -484 | -301 | N/A | -3 |
| Net Income Continuous | 1,488 | -15,058 | -13,582 | -8,057 | -6,599 |
| Net Income | $1,488 | $-15,058 | $-13,582 | $-8,057 | $-6,605 |
| EPS Basic Total Ops | 0.00 | -0.06 | -0.14 | -0.11 | -0.27 |
| EPS Basic Continuous Ops | 0.00 | -0.06 | -0.14 | -0.11 | -0.21 |
| EPS Diluted Total Ops | 0.00 | -0.06 | -0.14 | -0.11 | -0.27 |
| EPS Diluted Continuous Ops | 0.00 | -0.06 | -0.14 | -0.11 | -0.21 |
| EBITDA(a) | $-1,140 | $-1,482 | $-402 | $-1,428 | $-5,890 |